1. Cancer Statistics, 2021;Siegel;CA Cancer J Clin,2021
2. Flaig TW, Spiess PE, Chair V, et al. NCCN Guidelines Version 2.2022 Bladder Cancer.; 2022. Available at: https://www.nccn.org/home/member. Accessed August 30, 2022
3. Treatment of patients with metastatic urothelial cancer “Unfit” for cisplatin-based chemotherapy;Galsky;J Clin Oncol,2011
4. Mechanisms of resistance to immune checkpoint inhibitors;Jenkins;Br J Cancer,2018
5. CTLA-4 and PD-1 pathways similarities, differences, and implications of their inhibition;Buchbinder;Am J Clin Oncol,2016